As part of a planned transition, Ronald A. Rittenmeyer steps down as chairman and CEO and will serve in an advisory role through the end of the year.
Strickland joined Millennium Health in 2011 building the clinical and education teams and later served as the general manager of the pharmacogenetic testing and medication monitoring business lines. In her most recent role as COO, she has led laboratory and commercial operations, managed markets, and genetics R and D to successful growth, and has improved business efficiencies and expansion into new markets.
Prior to Millennium, Strickland served in numerous leadership roles in pharmacy and pain management within hospitals, including Lakeland Regional Medical Center. She also served in various educator roles, including as a preceptor for doctor of pharmacy students and a residency director for a specialty pharmacy residency in pain and palliative care at the H. Lee Moffitt Cancer Center and Lakeland Regional Medical Center.
Strickland received her doctor of pharmacy degree from the University of Florida College of Pharmacy and subsequently completed a specialty pharmacy residency in pain management at the H. Lee Moffitt Cancer Center in Tampa, Fla.
She is published in the areas of pain management and palliative care and has spoken nationally on related topics, including opioid pharmacology, risk management in chronic pain patients, and adjuvant pharmacotherapy for chronic pain.
Millennium Health delivers accurate, timely, clinically actionable information to inform the right treatment decisions for each patient. The company offers a comprehensive suite of services which can be used to better tailor patient care.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer